Amylin Pharmaceuticals lobbies on its own behalf. For Q3 2012 it reported $170K across 1 client report and lists 4 lobbyists across its filings. Issues include Medicare/Medicaid, Health Issues, Budget/Appropriations and Pharmacy.
| Client | Reported | Issues |
|---|---|---|
| AMYLIN PHARMACEUTICALS | $170K | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| Year | Reported | Clients |
|---|---|---|
| 2012 | $770K | 1 |
| 2011 | $960K | 1 |
| 2010 | $960K | 1 |
| 2009 | $1.25M | 1 |
| 2008 | $1.67M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.